Supplemental Financial Information (Tables)

12 Months Ended

Dec. 31, 2025

Balance Sheet Related Disclosures [Abstract]

Schedule of Property, Plant and Equipment Net

Property, plant and equipment, net consisted of the following (in thousands):

	December 31, 2025			December 31, 2024
Leasehold improvements	$	2,152		$	2,117
Laboratory equipment		3,306			3,130
Computer equipment		749			707
Furniture and fixtures		921			864
Construction in progress		4,292			4,251
		11,420			11,069
Accumulated depreciation		(4,684	)		(3,584	)
Property, plant and equipment, net	$	6,736		$	7,485

Schedule of Accrued Expenses and Other Current Labilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	December 31, 2025		December 31, 2024
Accrued compensation	$	9,425	$	5,242
Accrued research and development		3,591		1,714
Accrued clinical trial		3,290		1,907
Lease liabilities, current portion		1,865		1,877
Warrant liability		—		438
Accrued professional and consulting fees		1,310		725
Accrued property, plant and equipment		19		207
Other		777		752
Total accrued expenses and other current liabilities	$	20,277	$	12,862

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	December 31, 2025		December 31, 2024
Prepaid research and development	$	2,460	$	841
Prepaid clinical trial		866		1,112
Deferred offering costs		195		135
Prepaid insurance		108		249
Other		802		308
Total prepaid expenses and other current assets	$	4,431	$	2,645